Figure 1.
A schematic representation of the study design. This study was aimed at predicting novel drug targets for DN based on the holistic molecular pathogenesis map. Using different experimental and computational methods, the central nodes, key interactions, and signaling pathways of DN were identified. To translate the findings to clinical application, a high-performance machine learning framework, mGMDH-AFS, was developed and validated to predict drug targets for all human proteins. This classifier was then applied to candidate novel therapeutic targets in the constructed holistic map of DN. miRs: microRNAs; PPI: protein–protein interaction network.
